-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Management Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
- Monitoring and Evaluation
- Principal Recipient Start-Up
-
Procurement and Supply Management
- Development of List of Health Products and Procurement Action Plan
- Distribution and Inventory Management
- Overview
- Price and Quality Reporting (PQR) System
- Procurement of Non-health Products and Services
- Procurement of Pharmaceutical and Other Health Products
- Quality Control
- Rational use of Medicines and Pharmacovigilance Systems
- Strengthening of PSM Services and Risk Mitigation
- UNDP Health PSM Roster
- UNDP Quality Assurance Policy and Plan
-
Reporting
- Communicating Results
- Grant Performance Report
- Overview
- Performance-based Funding and Disbursement Decision
- PR and Coordinating Mechanism (CM) Communication and Governance
- Reporting to the Global Fund
- UNDP Corporate Reporting
-
Risk Management
- Common Risks Identified in Global Fund Programmes
- Global Fund Risk Management
- Introduction to Risk Management
- Overview
- Risk Management in High Risk Environments
- Risk Management in UNDP-managed Global Fund Grants
- Risk management in UNDP
- UNDP Risk Management in the Global Fund Portfolio
- Sub-Recipient Management
Development of List of Health Products and Procurement Action Plan
The Global Fund requires all Principal Recipients (PRs) to have a detailed approved list of health products, with quantities and costs, including any and all related procurement and supply management costs before any funds are spent on pharmaceuticals or other health products. The list of health products, quantities and costs is incorporated into the standard template, which is aligned with the detailed budget template. The PR should also attach supporting documentation with the relevant quantification, hypotheses and assumptions used to calculate the quantities listed. The list constitutes the basis of a Procurement Action Plan (PAP) that should be developed by the Country Office (CO) as soon as possible—preferably before the programme begins.
The PAP needs to be reviewed and updated by the CO every year. COs that implement Global Fund grants are not required to submit a CO’s PAP that also includes a PAP for Global Fund grants. An annual PAP for Global Fund grants is prepared separately by the Project Management Unit (PMU) and sent to Cécile Mace for consolidation of the global procurement forecast and monitoring. Some pharmaceutical and other medical products have long lead times, and orders need to be placed at the beginning of the programme.
As the PR is not allowed to purchase pharmaceuticals or other medical products prior to approval of its list of health products, quantities and costs, delay in preparation of this key document and the PAP can delay programme implementation. The list should be developed according to the template prescribed by the Global Fund.

- Lack of specificity about which entities are responsible for each aspect of the PSM chain.
- Lack of information about the distribution and storage of products.
- Lack of details about quality assurance and quality control.
- Lack of due diligence with regard to verification of product compliance with the Global
Fund Quality Assurance (QA) policies, especially for pharmaceuticals and diagnostics.
- Lack of attention to intellectual property rights laws.
- Lack of attention to rational drug use.
- Failure to include a forecast or explanation of how quantities were determined.
- Inappropriate ‘cutting and pasting’ from the procurement plan of another office without an analysis of the specific problems in the country where the PSM is being implemented.
The list must be approved by the Global Fund during the grant-making process before any expenditure on pharmaceuticals or other health products can be made, unless a waiver is obtained in advance from the Global Fund.
Loading resources
